BS EN ISO 18704:2026

This standard BS EN ISO 18704:2026 Molecular in vitro diagnostic examinations. Requirements and recommendations for pre-examination processes for urine and other body fluids. Isolated cell-free DNA is classified in these ICS categories:

• 11.100.10 In vitro diagnostic test systems

This document specifies requirements and provides recommendations for the pre-examination process of cell-free DNA (cfDNA) from body fluid specimens other than blood, including but not limited to the collection, handling, storage, transport, processing and documentation of human body fluids, such as urine, pleural effusions, ascites, cerebrospinal fluid (CSF), and saliva, intended for cfDNA examination. Processing includes multiple steps, such as centrifugation for specimen purification and isolation of cfDNA. This document does not cover dedicated measures for cytohistological analysis of nucleated cells derived from body fluid, nor measures for preserving and handling of pathogens, and other bacterial or whole microbiome DNA in body fluids described. Dedicated measures for preserving circulating cell-free DNA (ccfDNA) from blood are covered in ISO 20186-3. This document is applicable to medical laboratories, health institutions including facilities collecting and handling specimens, laboratory customers, in vitro diagnostic examination developers and manufacturers, biobanks, institutions and organizations performing biomedical research, and regulatory authorities. NOTE            International, national or regional regulations or requirements can also apply to specific topics covered in this document.

BS EN ISO 18704:2026 - Molecular in vitro Diagnostic Examinations

Standard Number: BS EN ISO 18704:2026

Pages: 34

Released: February 26, 2026

ISBN: 978 0 539 24422 9

Status: Standard

Overview

Introducing the BS EN ISO 18704:2026, a comprehensive standard that sets the benchmark for molecular in vitro diagnostic examinations. This standard is pivotal for laboratories and healthcare facilities that focus on the pre-examination processes for urine and other body fluids, specifically targeting isolated cell-free DNA. With the rapid advancements in molecular diagnostics, this standard ensures that your processes are aligned with the latest international guidelines, enhancing the accuracy and reliability of diagnostic results.

Key Features

• Comprehensive Guidelines: This standard provides detailed requirements and recommendations for pre-examination processes, ensuring that all procedures are conducted with precision and care.
• Focus on Cell-Free DNA: Special emphasis is placed on the handling and examination of isolated cell-free DNA, a critical component in modern diagnostic practices.
• Applicable to Various Body Fluids: While urine is a primary focus, the standard also covers other body fluids, making it versatile and applicable to a wide range of diagnostic scenarios.
• Internationally Recognized: As an ISO standard, it is recognized globally, facilitating international collaboration and consistency in diagnostic practices.

Why Choose BS EN ISO 18704:2026?

In the ever-evolving field of molecular diagnostics, staying updated with the latest standards is crucial. The BS EN ISO 18704:2026 offers a robust framework that not only enhances the quality of diagnostic examinations but also ensures compliance with international best practices. By adhering to this standard, laboratories can significantly reduce the risk of errors, improve patient outcomes, and maintain a high level of trust and credibility in their diagnostic services.

Benefits of Compliance

Compliance with the BS EN ISO 18704:2026 standard brings numerous benefits, including:

• Improved Accuracy: By following the standardized procedures, laboratories can achieve more accurate and reliable diagnostic results.
• Enhanced Efficiency: Streamlined processes reduce the time and resources required for diagnostic examinations, leading to faster turnaround times.
• Increased Patient Trust: Patients can have greater confidence in the diagnostic results, knowing that they are based on internationally recognized standards.
• Regulatory Compliance: Adhering to this standard helps laboratories meet regulatory requirements, avoiding potential legal and financial repercussions.

Who Should Use This Standard?

The BS EN ISO 18704:2026 is essential for a wide range of professionals and organizations, including:

• Clinical Laboratories: Laboratories conducting molecular diagnostic examinations will find this standard invaluable for ensuring high-quality results.
• Healthcare Providers: Hospitals and clinics can enhance their diagnostic capabilities by implementing the guidelines outlined in this standard.
• Research Institutions: Academic and research institutions involved in molecular diagnostics can benefit from the comprehensive guidelines provided.
• Regulatory Bodies: Organizations responsible for overseeing diagnostic practices can use this standard as a benchmark for evaluating compliance.

Conclusion

The BS EN ISO 18704:2026 standard is a vital resource for anyone involved in molecular in vitro diagnostic examinations. By providing clear and detailed guidelines for pre-examination processes, it ensures that diagnostic practices are conducted with the highest level of accuracy and reliability. Whether you are a laboratory professional, healthcare provider, or regulatory body, this standard is an indispensable tool for achieving excellence in molecular diagnostics.

Embrace the future of diagnostic excellence with the BS EN ISO 18704:2026 standard and ensure that your practices are at the forefront of innovation and quality.